Pediatric Exclusivity Rules May Be Revisited
This article was originally published in The Pink Sheet Daily
Executive Summary
The rules governing pediatric exclusivity awards may be revisited as a result of the investigation into the handling of pediatric antidepressant safety data
You may also be interested in...
Sen. Gregg Plans Clinical Trials Legislation For This Congressional Session
The Senate Health Committee chairman’s bill would focus on “clinical trial database issues,” while legislation planned by Sens. Kennedy, Dodd and Johnson would be directed at FDA’s authority to disclose clinical trial results, a committee staffer says.
Sen. Gregg Plans Clinical Trials Legislation For This Congressional Session
The Senate Health Committee chairman’s bill would focus on “clinical trial database issues,” while legislation planned by Sens. Kennedy, Dodd and Johnson would be directed at FDA’s authority to disclose clinical trial results, a committee staffer says.
PhRMA Clinical Trial Registry Will Be Launched Oct. 1
Clinicalstudyresults.org will include results of all controlled “hypothesis testing” clinical trials completed since October 2002 for PhRMA member companies’ marketed products. Postings will include a drug’s label, a bibliography of published studies, and summaries of unpublished studies.